Infectious Disease Therapeutics Market Size, Share, Growth, and Industry Analysis, By Type (Drugs, Vaccines), By Application (HIV/AIDS, Influenza, Hepatitis, Malaria, Tuberculosis, Others), Regional Insights and Forecast to 2033

Detailed TOC of Global Infectious Disease Therapeutics Market Research Report 2022

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Infectious Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 HIV/AIDS
1.3.3 Influenza
1.3.4 Hepatitis
1.3.5 Malaria
1.3.6 Tuberculosis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Therapeutics Market Perspective (2017-2028)
2.2 Infectious Disease Therapeutics Growth Trends by Region
2.2.1 Infectious Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Therapeutics Market Dynamics
2.3.1 Infectious Disease Therapeutics Industry Trends
2.3.2 Infectious Disease Therapeutics Market Drivers
2.3.3 Infectious Disease Therapeutics Market Challenges
2.3.4 Infectious Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Therapeutics Players by Revenue
3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
3.4 Global Infectious Disease Therapeutics Market Concentration Ratio
3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2021
3.5 Infectious Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Infectious Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Therapeutics Breakdown Data by Type
4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Therapeutics Breakdown Data by Application
5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Therapeutics Market Size (2017-2028)
6.2 North America Infectious Disease Therapeutics Market Size by Country (2017-2022)
6.3 North America Infectious Disease Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Therapeutics Market Size (2017-2028)
7.2 Europe Infectious Disease Therapeutics Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Therapeutics Market Size (2017-2028)
9.2 Latin America Infectious Disease Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Infectious Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 Gilead
11.2.1 Gilead Company Detail
11.2.2 Gilead Business Overview
11.2.3 Gilead Infectious Disease Therapeutics Introduction
11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.2.5 Gilead Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Detail
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Janssen Pharmaceutical Inc.
11.4.1 Janssen Pharmaceutical Inc. Company Detail
11.4.2 Janssen Pharmaceutical Inc. Business Overview
11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.4.5 Janssen Pharmaceutical Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 BioCryst Pharmaceuticals Inc.
11.6.1 BioCryst Pharmaceuticals Inc. Company Detail
11.6.2 BioCryst Pharmaceuticals Inc. Business Overview
11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.6.5 BioCryst Pharmaceuticals Inc. Recent Development
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Detail
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.7.5 Merck & Co. Inc. Recent Development
11.8 Boehringer Ingelheim GmbH
11.8.1 Boehringer Ingelheim GmbH Company Detail
11.8.2 Boehringer Ingelheim GmbH Business Overview
11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.8.5 Boehringer Ingelheim GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details